Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra®) for erectile dysfunction:: a multicentre, randomised, double-blind, placebo-controlled trial

被引:68
|
作者
Heiman, J. R.
Talley, D. R.
Bailen, J. L.
Oskin, T. A.
Rosenberg, S. J.
Pace, C. R.
Creanga, D. L.
Bavendam, T.
机构
[1] Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Bloomington, IN 47405 USA
[2] Urol San Antonio Res, San Antonio, TX USA
[3] Metropolitan Urol, Jefferson, IN USA
[4] Northside Internal Med, Spokane, WA USA
[5] Iowa Clin PC, Des Moines, IA USA
[6] Pfizer Inc, New York, NY USA
关键词
couples; erectile dysfunction; relations; sexual partner; sildenafil citrate;
D O I
10.1111/j.1471-0528.2006.01228.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To investigate the effect of improvement in erectile dysfunction (ED) on sexual function and satisfaction measures in heterosexual couples in which the woman reports that sexual intercourse is unsatisfactory at least half of the time. Design Multicentre, double-blind, placebo-controlled study. Setting Outpatient medical clinics. Population Hundred and eighty men with ED and their female partners in whom sexual intercourse was satisfactory about half the time or less (score of <= 3 on the Female Partner of ED Subject Questionnaire question 3 [FePEDS Q3]). Methods Men were randomised to flexible-dose sildenafil (25, 50, and 100 mg) or placebo as needed for 12 weeks. Main outcome measures Primary: FePEDS Q3 ('Over the past four weeks, when you had sexual intercourse, how often was it satisfactory for you?') scored as 0 (no sexual activity) and 1 (almost never or never) to 5 (almost always or always). Secondary, partners: Sexual Function Questionnaire, Female Sexual Function Index (FSFI), and ED Inventory of Treatment Satisfaction (EDITS) partner version (EDITS-Partner). Secondary, men: International Index of Erectile Function (IIEF), General Efficacy Questions, event log data, Self-Esteem And Relationship questionnaire, and EDITS. Secondary, partners and men: Dyadic Adjustment Scale. Results The intention-to-treat population included 85 sildenafil recipients (mean age 59 +/- 12 years) and 91 placebo recipients (mean age 57 +/- 11 years). Most partners (aged 20-79 years; mean, 54 years) were postmenopausal. Sildenafil compared with placebo couples had greater improvement in the primary outcome (FePEDS Q3 [P < 0.0001]) and in sexual function, intercourse success rates, and secondary sexual satisfaction measures (FSFI satisfaction domain [P < 0.0001] and IIEF satisfaction domains [P < 0.001]) and had higher treatment satisfaction (EDITS and EDITS-Partner; P < 0.0001). Several predictors of improvement were identified, and improvement in one member of the couple correlated positively with improvement in the other member. Conclusions The interdependence of sexual function and sexual satisfaction measures between members of couples consisting of men with ED and sexually healthy women reporting infrequent satisfactory sexual intercourse underscores the importance of including partners in ED treatment discussions.
引用
收藏
页码:437 / 447
页数:11
相关论文
共 50 条
  • [1] Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: A multicentre, randomized, doubleblind, placebo-controlled trial
    Krychman, Michael L.
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (03): : 533 - 534
  • [2] Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction: A Double-Blind, Placebo-Controlled Clinical Trial
    Moncada, Ignacio
    Martinez-Jabaloyas, Jose M.
    Rodriguez-Vela, Luis
    Gutierrez, Pedro R.
    Giuliano, Francois
    Koskimaki, Juha
    Farmer, Ian S.
    Pascual Renedo, Virginia
    Schnetzler, Gabriel
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (12): : 3469 - 3477
  • [3] A Multicenter, Double-blind, Placebo-controlled Trial to Assess The Efficacy of Sildenafil Citrate in Men With Unrecognized Erectile Dysfunction
    Shabsigh, Ridwan
    Kaufman, Joel
    Magee, Michelle
    Creanga, Dana
    Russell, David
    Budhwani, Meeta
    UROLOGY, 2010, 76 (02) : 373 - 379
  • [4] A placebo-controlled, double-blind trial of sildenafil citrate in women with sexual arousal disorder
    Berman, JR
    Berman, LA
    Toler, SM
    Gill, JM
    Haughie, S
    JOURNAL OF UROLOGY, 2003, 169 (04): : 97 - 97
  • [5] A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer
    Ilic, Dragan
    Hindson, Ben
    Duchesne, Gillian
    Millar, Jeremy L.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2013, 57 (01) : 81 - 88
  • [6] Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial
    Goldstein, I
    Fisher, WA
    Sand, M
    Rosen, RC
    Mollen, M
    Brock, G
    Karlin, G
    Pommerville, P
    Bangerter, K
    Bandel, TJ
    Derogatis, LR
    JOURNAL OF SEXUAL MEDICINE, 2005, 2 (06): : 819 - 832
  • [7] Female partners of men with erectile dysfunction treated with sildenafil citrate report greater satisfaction and enjoyment from sexual intercourse: A multicenter, randomized, double-blind, placebo-controlled study
    Heiman, JR
    Talley, DR
    Bailen, JL
    Shumel, B
    Pace, CR
    Creanga, DL
    Bavendam, T
    JOURNAL OF UROLOGY, 2005, 173 (04): : 5 - 5
  • [8] Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra®) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease
    Lindsey, I
    George, B
    Kettlewell, M
    Mortensen, N
    DISEASES OF THE COLON & RECTUM, 2002, 45 (06) : 727 - 732
  • [10] Assessing Self-Esteem, Confidence, and Relationships In Men With Erectile Dysfunction Treated With VIAGRA® (Sildenafil Citrate): Results From Mexican Centers of an International, Multicenter, Double-Blind, Placebo-Controlled Trial
    Calvo Dominguez, D.
    Ballesteros Villalobos, R.
    Francolugo-Velez, V.
    Moy-Eransus, C.
    Orozco Bravo, A.
    Pacheco Gahbler, C.
    Perez-Toriz, U.
    Rodriguez Rivera, A.
    Zonana Farca, E.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 43 - 43